$5.32
Price
$1.9B
Market Cap
—
P/E Ratio
-24.2
Forward P/E
$-1.21
EPS (TTM)
—
Dividend Yield
$56M
Cash
$98M
Total Debt
357M
Shares Out
$1.47
$6.04
52-Week Range
Institutional Ownership of PRECIGEN INC
|
Fund / Manager
Click to search
|
Shares | Value | % of Portfolio | Cost Basis | Est. Return |
|---|---|---|---|---|---|
|
Patient Capital Management|Samantha McLemore
|
17.8M | $69M | — | — |
Trading Activity for PRECIGEN INC
|
Fund / Manager
Click to search
|
Action | Change | Shares After | Value | Price |
|---|---|---|---|---|---|
| 2026-Q1 | |||||
| SELL | -4.6% | 17.8M | $69M | $4.21 | |
| 2025-Q4 | |||||
| SELL | -29.4% | 18.7M | $78M | $3.90 | |
| 2025-Q3 | |||||
| BUY | +62.6% | 26.5M | $87M | $1.95 | |
| 2025-Q2 | |||||
| SELL | -6.3% | 16.3M | $23M | $1.41 | |
| 2025-Q1 | |||||
| SELL | -2.9% | 17.4M | $26M | $1.70 | |
| 2024-Q4 | |||||
| SELL | -0.3% | 17.9M | $20M | $0.85 | |
| 2024-Q3 | |||||
| SELL | -1.3% | 17.9M | $17M | $1.15 | |
| 2024-Q2 | |||||
| BUY | +4.1% | 18.2M | $29M | $1.40 | |
| 2024-Q1 | |||||
| BUY | +9.2% | 17.5M | $25M | $1.41 | |
| 2023-Q4 | |||||
| BUY | +16.2% | 16.0M | $21M | $1.16 | |
| 2023-Q3 | |||||
| BUY | +22.3% | 13.8M | $20M | $1.40 | |
| 2023-Q2 | |||||
| BUY | +668.1% | 11.2M | $13M | $1.20 | |
| SELL | EXIT | — | — | $1.20 | |
| 2023-Q1 | |||||
| BUY | NEW | 9.5M | $10M | $1.48 | |
| BUY | +83.4% | 1.5M | $2M | $1.48 | |
| 2022-Q4 | |||||
| BUY | +167.7% | 798.2K | $1M | $1.72 | |
| 2022-Q3 | |||||
| SELL | EXIT | — | — | $2.14 | |
| 2022-Q2 | |||||
| SELL | -12.4% | 5.6M | $8M | $1.36 | |
| SELL | -60.1% | 298.2K | $400000 | $1.36 | |
| 2022-Q1 | |||||
| SELL | -0.7% | 6.4M | $13M | $2.21 | |
| BUY | +150.9% | 748.2K | $2M | $2.21 | |
| 2021-Q4 | |||||
| SELL | -20.2% | 6.4M | $24M | $4.16 | |
| 2021-Q3 | |||||
| SELL | -12.9% | 8.1M | $40M | $5.70 | |
| 2021-Q2 | |||||
| BUY | +1.7% | 9.3M | $60M | $6.82 | |
| 2021-Q1 | |||||
| BUY | +27.6% | 9.1M | $63M | $8.45 | |
| 2020-Q4 | |||||
| SELL | -5.6% | 7.1M | $73M | $5.94 | |
| 2020-Q3 | |||||
| SELL | -2.1% | 7.6M | $26M | $4.74 | |
| 2020-Q2 | |||||
| BUY | +3.7% | 7.7M | $39M | $3.23 | |
| 2020-Q1 | |||||
| BUY | NEW | 7.4M | $25M | $4.42 | |
Insider Trading for PRECIGEN INC
No Insider Transactions
No Form 4 filings found for this stock in the last 2 years.